Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus

Fibromax is a diagnostic tool composed of the combination of 4 non-invasive biomarker panels for the diagnosis of steatosis (SteatoTest), necrosis and inflammation (ActiTest and NashTest-2) and fibrosis (FibroTest). The purpose of this study was to assess the performance of these biomarker panels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bril, Fernando, McPhaul, Michael J, Caulfield, Michael P, Castille, Jean-Marie, Poynard, Thierry, Soldevila-Pico, Consuelo, Clark, Virginia C, Firpi-Morell, Roberto J, Lai, Jinping, Cusi, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581087/
https://www.ncbi.nlm.nih.gov/pubmed/30309884
http://dx.doi.org/10.1136/jim-2018-000864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581087/
https://www.ncbi.nlm.nih.gov/pubmed/30309884
http://dx.doi.org/10.1136/jim-2018-000864

Ejemplares similares